research 572 Development of immunotherapies targeting TCR-Vβ2 for treatment of cutaneous T cell lymphoma
Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.



Chennai, Tamil Nadu, India
Bengaluru, Karnataka, India
Pimpri-Chinchwad, Maharashtra, India
Chatswood, NSW, Australia
Taipei City, Taiwan
New Delhi, Delhi, India